Evidence map›Paper›PMID 38089942›Full record

ReviewCureus2023

Midazolam for Anesthetic Premedication in Children: Considerations and Alternatives.

Michael Lethin, Matthew R Paluska, Timothy R Petersen, Ricardo Falcon, Codruta Soneru

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Incidence and predictors of nonresponse to intranasal midazolam in children undergoing laceration repair.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Michael LethinDepartment of Internal Medicine, Western University of Health Sciences College of Osteopathic Medicine of the Pacific-Northwest, Lebanon, USA.
Matthew R PaluskaDepartment of Anesthesiology, Rocky Vista University College of Osteopathic Medicine, Englewood, USA.
Timothy R PetersenOffice of Graduate Medical Education/Department of Anesthesiology and Critical Care/Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, Albuquerque, USA.
Ricardo FalconDepartment of Anesthesiology and Critical Care, University of New Mexico School of Medicine, Albuquerque, USA.
Codruta SoneruDepartment of Anesthesiology and Critical Care, University of New Mexico School of Medicine, Albuquerque, USA.
Pacific Northwest University of Health Sciences · USRocky Vista University · USUniversity of New Mexico · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Premedication in anesthesia has long been used to reduce patient anxiety, increase patient compliance, and supplement the overall anesthetic. In pediatric populations, premedication also has the indirect benefits of reducing parental anxiety as well as both the incidence and severity of emergence delirium. Oral midazolam, selected for its ease of administration, short duration of action, and reliable anxiolytic and amnestic effects, has been a favorite choice in this role for decades. The side effect profile of midazolam is also relatively benign, heavily dose-dependent, and easily managed in the perioperative setting. While midazolam appears to be an ideal adjunct in the anesthetic care of pediatric patients, there is a growing body of evidence suggesting prolonged benzodiazepine exposure causes neurodevelopmental changes in infants. This evidence, along with the 2017 Food and Drug Administration (FDA) warning labels for the use of select anesthetic medications, including midazolam in children under the age of three, has led to some debate in the anesthetic community over the continued use of this anesthetic for premedication in pediatric populations. This article aims to educate the reader on the history of midazolam as a premedication agent in pediatric populations and examine the evidence supporting and against its continued use in this role.

Indexed as

anesthetic agentsanxiolysisanxiolytic effectmidazolampediatric anesthesiapediatric premedicationpediatric surgerypharmacokinetics in childrenpreoperative caresedation

Identifiers

PMID38089942
PMCPMC10711689
OpenAlexW4389564700

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.